{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:21:46Z","timestamp":1790011306769,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijid.2021.05.085","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T14:13:16Z","timestamp":1622815996000},"page":"510-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Combination of aztreonam, ceftazidime\u2013avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8612-5581","authenticated-orcid":false,"given":"Alessandra","family":"Mularoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Mezzatesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-070X","authenticated-orcid":false,"given":"Alice Annalisa","family":"Medaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-7847","authenticated-orcid":false,"given":"Adriana","family":"Cervo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne","family":"Bongiorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausilia","family":"Aprile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-5061","authenticated-orcid":false,"given":"Paolo","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.05.085_bib0005","article-title":"In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates","volume":"7","author":"Aprile","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2021.05.085_bib0010","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1128\/AAC.00206-15","article-title":"In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013","volume":"59","author":"Biedenbach","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijid.2021.05.085_bib0015","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1128\/JCM.42.12.5644-5649.2004","article-title":"Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa","volume":"42","author":"Curran","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2021.05.085_bib0020","first-page":"ciaa586","article-title":"Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL-producing Enterobacterales","volume":"19","author":"Falcone","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"31","key":"10.1016\/j.ijid.2021.05.085_bib0025","doi-asserted-by":"crossref","first-page":"e7664","DOI":"10.1097\/MD.0000000000007664","article-title":"Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury: a case report","volume":"96","author":"Gugliandolo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijid.2021.05.085_bib0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s15010-020-01520-6","article-title":"Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems","volume":"48","author":"Karakonstantis","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2021.05.085_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6845985","article-title":"Prevalence of Extended Spectrum Betalactamase (ESBL) and Metallobetalactamase (MBL) producing Pseudomonas aeruginosa and Acinetobacter baumannii isolated from various clinical samples","volume":"2018","author":"Kaur","year":"2018","journal-title":"J Pathog"},{"key":"10.1016\/j.ijid.2021.05.085_bib0040","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1128\/AAC.02894-14","article-title":"Bactericidal activity, absence of serum effect, and time-kill kinetics of ceftazidime-avibactam against \u03b2-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa","volume":"58","author":"Keepers","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.05.085_bib0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jinf.2017.06.006","article-title":"Successful treatment of Pseudomonas aeruginosa osteomyelitis with antibiotic monotherapy of limited duration","volume":"75","author":"Laghmouche","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2021.05.085_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115227","article-title":"Activity of aztreonam in combination with ceftazidime\u2013avibactam against serine- and metallo-\u03b2-lactamase\u2013producing-Pseudomonas aeruginosa","volume":"99","author":"Lee","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2021.05.085_bib0055","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.04191-14","article-title":"In vitro susceptibility of characterized \u03b2-lactamase-producing strains tested with avibactam combinations","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2021.05.085_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02243-16","article-title":"Can ceftazidime\u2013avibactam and aztreonam overcome \u03b2-lactam resistance conferred by metallo-\u03b2-lactamases in Enterobacteriaceae?","volume":"61","author":"Marshall","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.05.085_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11908-018-0629-6","article-title":"Multidrug-resistant Pseudomonas infections: hard to treat, but hope on the horizon?","volume":"20","author":"Nguyen","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijid.2021.05.085_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones","volume":"21\u201322","author":"Oliver","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2021.05.085_bib0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jcf.2018.01.007","article-title":"Chronic infection sustained by a Pseudomonas aeruginosa high-risk clone producing the VIM-1 metallo-\u03b2-lactamase in a cystic fibrosis patient after lung transplantation","volume":"17","author":"Pollini","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijid.2021.05.085_bib0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.ccm.0000626168.71940.57","article-title":"Ceftazidime-avibactam and aztreonam against multidrug-resistant Pseudomonas aeruginosa","volume":"48","author":"Toor","year":"2020","journal-title":"Crit Care Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:01:47Z","timestamp":1761120107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221004896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":16,"alternative-id":["S1201971221004896"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.085","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of aztreonam, ceftazidime\u2013avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}